BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20600071)

  • 1. Schistosoma mansoni host-exposed surface antigens characterized by sera and recombinant antibodies from schistosomiasis-resistant rats.
    Sepulveda J; Tremblay JM; DeGnore JP; Skelly PJ; Shoemaker CB
    Int J Parasitol; 2010 Oct; 40(12):1407-17. PubMed ID: 20600071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schistosoma mansoni Infection of Mice, Rats and Humans Elicits a Strong Antibody Response to a Limited Number of Reduction-Sensitive Epitopes on Five Major Tegumental Membrane Proteins.
    Krautz-Peterson G; Debatis M; Tremblay JM; Oliveira SC; Da'dara AA; Skelly PJ; Shoemaker CB
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005306. PubMed ID: 28095417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection.
    Cardoso FC; Macedo GC; Gava E; Kitten GT; Mati VL; de Melo AL; Caliari MV; Almeida GT; Venancio TM; Verjovski-Almeida S; Oliveira SC
    PLoS Negl Trop Dis; 2008 Oct; 2(10):e308. PubMed ID: 18827884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human IgG1 Responses to Surface Localised Schistosoma mansoni Ly6 Family Members Drop following Praziquantel Treatment.
    Chalmers IW; Fitzsimmons CM; Brown M; Pierrot C; Jones FM; Wawrzyniak JM; Fernandez-Fuentes N; Tukahebwa EM; Dunne DW; Khalife J; Hoffmann KF
    PLoS Negl Trop Dis; 2015; 9(7):e0003920. PubMed ID: 26147973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of Schistosoma mansoni tegument annexins and comparative analysis of antibody responses following parasite infection.
    Leow CY; Willis C; Leow CH; Hofmann A; Jones M
    Mol Biochem Parasitol; 2019 Dec; 234():111231. PubMed ID: 31628972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that the reduced surface antigenicity of developing Schistosoma mansoni schistosomula is due to antigen shedding rather than host molecule acquisition.
    Pearce EJ; Basch PF; Sher A
    Parasite Immunol; 1986 Jan; 8(1):79-94. PubMed ID: 2421228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies.
    Cardoso FC; Pacífico RN; Mortara RA; Oliveira SC
    Clin Exp Immunol; 2006 Jun; 144(3):382-91. PubMed ID: 16734606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schistosoma mansoni gene GP22 encodes the tegumental antigen sm25: (1) antibodies to a predicted B-cell epitope of Sm25 cross-react with other candidate vaccine worm antigens; (2) characterization of a recombinant product containing tandem-repeats of this peptide as a vaccine.
    Petzke MM; Suri PK; Bungiro R; Goldberg M; Taylor SF; Ranji S; Taylor H; McCray JW; Knopf PM
    Parasite Immunol; 2000 Aug; 22(8):381-95. PubMed ID: 10972845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schistosoma mansoni phosphofructokinase: immunolocalization in the tegument and immunogenicity.
    Mansour JM; McCrossan MV; Bickle QD; Mansour TE
    Parasitology; 2000 May; 120 ( Pt 5)():501-11. PubMed ID: 10840980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of host antibody in the chemotherapeutic action of praziquantel against Schistosoma mansoni: identification of target antigens.
    Brindley PJ; Strand M; Norden AP; Sher A
    Mol Biochem Parasitol; 1989 May; 34(2):99-108. PubMed ID: 2496307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection.
    Gonçalves de Assis NR; Batistoni de Morais S; Figueiredo BC; Ricci ND; de Almeida LA; da Silva Pinheiro C; Martins Vde P; Oliveira SC
    PLoS One; 2015; 10(5):e0125075. PubMed ID: 25942636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incubation of Schistosoma mansoni lung-stage schistosomula in corn oil exposes their surface membrane antigenic specificities.
    El Ridi R; Mohamed SH; Tallima H
    J Parasitol; 2003 Oct; 89(5):1064-7. PubMed ID: 14627160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and testing of PCR primers for the construction of scFv libraries representing the immunoglobulin repertoire of rats.
    Sepulveda J; Shoemaker CB
    J Immunol Methods; 2008 Mar; 332(1-2):92-102. PubMed ID: 18242637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the use of C-terminal part of the Schistosoma mansoni 200kDa tegumental protein in schistosomiasis diagnosis and vaccine formulation.
    Carvalho GB; Pacífico LG; Pimenta DL; Siqueira LM; Teixeira-Carvalho A; Coelho PM; Pinheiro Cda S; Fujiwara RT; Oliveira SC; Fonseca CT
    Exp Parasitol; 2014 Apr; 139():24-32. PubMed ID: 24560833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies are involved in the protective immunity induced in mice by Schistosoma mansoni schistosomula tegument (Smteg) immunization.
    Melo TT; Sena IC; Araujo N; Fonseca CT
    Parasite Immunol; 2014 Feb; 36(2):107-11. PubMed ID: 24558655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schistosoma mansoni Stomatin like protein-2 is located in the tegument and induces partial protection against challenge infection.
    Farias LP; Cardoso FC; Miyasato PA; Montoya BO; Tararam CA; Roffato HK; Kawano T; Gazzinelli A; Correa-Oliveira R; Coulson PS; Wilson RA; Oliveira SC; Leite LC
    PLoS Negl Trop Dis; 2010 Feb; 4(2):e597. PubMed ID: 20161725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective monoclonal antibodies from mice vaccinated or chronically infected with Schistosoma mansoni that recognize the same antigens.
    Gregoire RJ; Shi MH; Rekosh DM; Loverde PT
    J Immunol; 1987 Dec; 139(11):3792-801. PubMed ID: 2445819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody responses to the fucosylated LacdiNAc glycan antigen in Schistosoma mansoni-infected mice and expression of the glycan among schistosomes.
    Nyame AK; Leppänen AM; Bogitsh BJ; Cummings RD
    Exp Parasitol; 2000 Dec; 96(4):202-12. PubMed ID: 11162373
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Morais SB; Figueiredo BC; Assis NRG; Homan J; Mambelli FS; Bicalho RM; Souza C; Martins VP; Pinheiro CS; Oliveira SC
    Front Immunol; 2018; 9():1762. PubMed ID: 30105029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential protective impact of peptide vaccine formulae targeting the lung- and liver-stage of challenge Schistosoma mansoni infection in mice.
    Tallima H; Tadros MM; El Ridi R
    Acta Trop; 2024 Jun; 254():107208. PubMed ID: 38621620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.